UnitedHealth Stalls on Delayed Commercial Margin Recovery Pressuring US30
UnitedHealth faces prolonged margin headwinds as elevated commercial medical costs and arbitration expenses offset Medicare gains. With commercial book recovery pushed beyond 2027, the stock's 41% re…